In parts of Uganda, children often face repeated malaria infections - yet some rarely become severely ill. Why?

New research from PhD candidate Jason Fairbank Nideffer, Prasanna Jagannathan, MD, and Maria Grazia Roncarolo, MD, in collaboration with Ugandan researchers, suggests their immune systems may have learned to stay calm rather than overreact. That insight could chart a path to a new kind of vaccine - one that doesn't block infection, but prevents disease.

In this breakthrough discovery, the scientists identified a little-known group of T cells called Tr1 cells that may hold the key. Instead of attacking the malaria parasite, these cells regulate the immune response, preventing dangerous inflammation.

This immune "braking system" may explain why some children stay well despite repeated infections. And it could pave the way for next-generation vaccines that train the immune system to tolerate malaria - and possibly other diseases - without severe illness.

Watch how this discovery could transform vaccine strategies for malaria - and beyond.